London‑based GHO Capital Partners and Asian‑focused CBC Group disclosed plans to merge, creating what they call the world's largest healthcare private equity investor. The deal joins a trans‑Atlantic services‑oriented platform with a trans‑Pacific therapeutics specialist, promising a unified asset manager that can source deals across both markets. Co‑chief executives say the union will reshape capital flows in the sector.

Investors have chased cross‑border opportunities as aging populations and tech‑driven therapies drive spend. GHO’s strong foothold in European hospitals complements CBC’s pipeline‑focused funds in China and Japan, giving the new firm leverage to back late‑stage biotech and platform acquisitions. Analysts estimate the combined assets could exceed $10 billion, a scale that may pressure rivals to consolidate.

Regulators in both regions will scrutinise the merger for antitrust concerns, but both parties argue the global reach improves patient access to capital and innovation. By aligning deal pipelines, the entity aims to accelerate funding cycles and lower transaction costs for providers. The merger sets a new benchmark for scale in healthcare private equity.

The combined platform will operate from London with satellite offices in Shanghai and Tokyo, preserving each legacy firm's investment teams. Early client feedback suggests appetite for a single adviser capable of navigating regulatory environments on both sides of the Pacific. With capital commitments already lined up, the merged firm is poised to close the transaction by year‑end.